These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8138267

  • 21. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N, Adams PC, Myers P, Simon V, Minuk GY, Wall W, Ghent CN.
    Transplantation; 2007 Jun 27; 83(12):1571-6. PubMed ID: 17589339
    [Abstract] [Full Text] [Related]

  • 22. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 27; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES, Newell KA, Haas M, Bartosh S, Josephson MA, Millis JM, Bruce DS, Piper JB, Aronson AJ, Thistlethwaite JR.
    Clin Transplant; 1997 Aug 27; 11(4):251-4. PubMed ID: 9267710
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
    Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Wahlstrom HE, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):665-8. PubMed ID: 7679835
    [No Abstract] [Full Text] [Related]

  • 30. [Rejection of a liver allograft. Diagnosis and treatment].
    Calmus Y.
    Ann Radiol (Paris); 1994 Feb 27; 37(5):377-82. PubMed ID: 7527621
    [Abstract] [Full Text] [Related]

  • 31. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D, Duvoux C, Salvat A, Lauzet JY, Metreau JM, Julien M, Fagniez PL, Dhumeaux D.
    Transplant Proc; 1995 Feb 27; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract] [Full Text] [Related]

  • 32. Successful withdrawal of corticosteroids in heart transplantation.
    Miller LW, Wolford T, McBride LR, Peigh P, Pennington DG.
    J Heart Lung Transplant; 1992 Feb 27; 11(2 Pt 2):431-4. PubMed ID: 1571342
    [Abstract] [Full Text] [Related]

  • 33. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC, Berisa F, McGonigle RJ, Adu D, Michael J, Barnes AD.
    Nephrol Dial Transplant; 1989 Feb 27; 4(2):129-32. PubMed ID: 2496354
    [Abstract] [Full Text] [Related]

  • 34. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC, Rohrer RM, Kaplan MM.
    Clin Transplant; 1995 Aug 27; 9(4):322-5. PubMed ID: 7579741
    [Abstract] [Full Text] [Related]

  • 35. Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients.
    Dunn SP, Falkenstein K, Lawrence JP, Meyers R, Vinocur CD, Billmire DF, Weintraub WH.
    Transplantation; 1994 Feb 27; 57(4):544-7. PubMed ID: 8116039
    [Abstract] [Full Text] [Related]

  • 36. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES, So S, Jendrisak MD, Perdrizet GA, White HM, Marsh JW.
    Transplant Proc; 1993 Apr 27; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract] [Full Text] [Related]

  • 37. Kidney function in heart-lung transplant recipients: the effect of low-dosage cyclosporine therapy.
    Imoto EM, Glanville AR, Baldwin JC, Theodore J.
    J Heart Transplant; 1987 Apr 27; 6(4):204-13. PubMed ID: 3117987
    [Abstract] [Full Text] [Related]

  • 38. Simultaneous quadruple immunosuppression with cyclosporine induction therapy in high risk renal transplant recipients.
    Indudhara R, Khauli RB, Menon M, Stoff JS.
    J Urol; 1994 Aug 27; 152(2 Pt 1):307-11. PubMed ID: 8015058
    [Abstract] [Full Text] [Related]

  • 39. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
    Carpenter CB, Milford EL, Kirkman RL, Strom TB, Lazarus JM, Tilney NL.
    Transplant Proc; 1985 Aug 27; 17(4 Suppl 1):261-5. PubMed ID: 3927537
    [Abstract] [Full Text] [Related]

  • 40. [Steroid withdrawal in renal transplant recipients].
    Nakamura H, Murai M, Asano T, Takao M, Yoshizawa N, Sekiguchi S.
    Nihon Jinzo Gakkai Shi; 1990 Sep 27; 32(9):1033-7. PubMed ID: 2263025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.